Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
Poultry Science
|
August 29, 2024
Pharmacokinetic modeling of sulfamethoxazole-trimethoprim and sulfadiazine-trimethoprim combinations in broilers
Marine Boulanger, Jean-François Taillandier, Jérôme Henri, et al.
BMC Veterinary Research
|
June 5, 2026
Comparative pharmacokinetics of trimethoprim-sulfadiazine and trimethoprim-sulfamethoxazole in dogs
Carl Ekstrand, Minerva Löwgren, Malin Erkas, et al.
Computer Methods in Biomechanics and Biomedical Engineering
|
December 15, 2010
Motion analysis of the glenohumeral joint during activities of daily living
B Lovern, L A Stroud, N A Ferran, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 7, 2023
Biased computation of probability of target attainment for antimicrobial drugs
Pierre-Louis Toutain, Peggy Gandia, Ludovic Pelligand, et al.
Clinical Pharmacokinetics
|
June 13, 2019
Authors' Reply to Castello-Bridoux et al.: "Comment on Levothyrox<sup>®</sup> New and Old Formulations: Are they Switchable for Millions of Patients?"
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, et al.
Clinical Pharmacokinetics
|
June 13, 2019
Author's Reply to Trechot: "Comment on Levothyrox<sup>®</sup> New and Old Formulations: Are they Switchable for Millions of Patients?"
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, et al.
Clinical Pharmacokinetics
|
June 5, 2019
Authors' Reply to Coste et al.: "Levothyrox<sup>®</sup> New and Old Formulations: Are they Switchable for Millions of Patients?"
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, et al.
Clinical Pharmacokinetics
|
August 28, 2019
Authors' Reply to Lechat et al.: "Levothyrox<sup>®</sup> New and Old Formulations: Are they Switchable for Millions of Patients?"
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, et al.
Frontiers in Pharmacology
|
December 3, 2024
Comparative bactericidal activity of four macrolides alone and combined with rifampicin or doxycycline against <i>Rhodococcus equi</i> at concentrations achievable in foals
Anne-Sophie Huguet, Ophélie Gourbeyre, Agathe Bernand, et al.
Clinical Pharmacokinetics
|
August 22, 2019
Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
Poultry Science
|
August 29, 2024
Pharmacokinetic modeling of sulfamethoxazole-trimethoprim and sulfadiazine-trimethoprim combinations in broilers
Marine Boulanger, Jean-François Taillandier, Jérôme Henri, et al.
BMC Veterinary Research
|
June 5, 2026
Comparative pharmacokinetics of trimethoprim-sulfadiazine and trimethoprim-sulfamethoxazole in dogs
Carl Ekstrand, Minerva Löwgren, Malin Erkas, et al.
Computer Methods in Biomechanics and Biomedical Engineering
|
December 15, 2010
Motion analysis of the glenohumeral joint during activities of daily living
B Lovern, L A Stroud, N A Ferran, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 7, 2023
Biased computation of probability of target attainment for antimicrobial drugs
Pierre-Louis Toutain, Peggy Gandia, Ludovic Pelligand, et al.
Clinical Pharmacokinetics
|
June 13, 2019
Authors' Reply to Castello-Bridoux et al.: "Comment on Levothyrox<sup>®</sup> New and Old Formulations: Are they Switchable for Millions of Patients?"
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, et al.
Clinical Pharmacokinetics
|
June 13, 2019
Author's Reply to Trechot: "Comment on Levothyrox<sup>®</sup> New and Old Formulations: Are they Switchable for Millions of Patients?"
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, et al.
Clinical Pharmacokinetics
|
June 5, 2019
Authors' Reply to Coste et al.: "Levothyrox<sup>®</sup> New and Old Formulations: Are they Switchable for Millions of Patients?"
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, et al.
Clinical Pharmacokinetics
|
August 28, 2019
Authors' Reply to Lechat et al.: "Levothyrox<sup>®</sup> New and Old Formulations: Are they Switchable for Millions of Patients?"
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, et al.
Frontiers in Pharmacology
|
December 3, 2024
Comparative bactericidal activity of four macrolides alone and combined with rifampicin or doxycycline against <i>Rhodococcus equi</i> at concentrations achievable in foals
Anne-Sophie Huguet, Ophélie Gourbeyre, Agathe Bernand, et al.
Clinical Pharmacokinetics
|
August 22, 2019
Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, et al.
Page
of 9